Bitterman Robert J Insider Trades & Stock Holdings

Chairman, Pres. & CEO · Phio Pharmaceuticals Corp. · Latest filing Sep 22, 2026

Bitterman Robert J, Chairman, Pres. & CEO at Phio Pharmaceuticals Corp. has 1 Form 4 trade on file since Sep 22, 2026. Open-market activity: 1 purchase ($2.06K) and 0 sales ($0), net +$2.06K. Latest filing: acquired 2K shares of $PHIO on Sep 22, 2026 at $1.03.

Trades on file

1

Open-market bought

$2.06K

Open-market sold

$0

Net open-market

+$2.06K

Latest filing

Sep 22, 2026

All insider trades by Bitterman Robert J

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 22, 2026	$PHIO	Buy (Open-market buy)	2K	$1.03	$2.06K						Chairman, Pres. & CEO		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Bitterman Robert J traded

• $PHIO

Frequently asked questions

Has Bitterman Robert J been buying or selling stock?

Bitterman Robert J has 1 open-market purchase and 0 open-market sales on file, net +$2.06K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Bitterman Robert J's latest insider trade?

acquired 2K shares of $PHIO on Sep 22, 2026 at $1.03.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.